Bacterial vaginosis as a factor associated with adverse pregnancy outcomes
- 作者: Oganyan K.A.1, Krysanova A.A.1, Savicheva A.M.1, Bespalova O.N.1, Kogan I.Y.1
-
隶属关系:
- The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
- 期: 卷 72, 编号 6 (2023)
- 页面: 129-138
- 栏目: Reviews
- ##submission.dateSubmitted##: 13.06.2023
- ##submission.dateAccepted##: 07.07.2023
- ##submission.datePublished##: 15.12.2023
- URL: https://journals.eco-vector.com/jowd/article/view/474063
- DOI: https://doi.org/10.17816/JOWD474063
- ID: 474063
如何引用文章
详细
Bacterial vaginosis is the most common disease of the genitals and affects 20–70% of women. This non-inflammatory syndrome is characterized by dysbiosis of the vaginal microbiota and is accompanied by a decrease in the number of lactobacilli. Bacterial vaginosis in 60% of pregnant women is asymptomatic, but can lead to obstetric complications such as late miscarriage, premature birth, fetal growth restriction, premature rupture of membranes, choriominionitis, postpartum endometritis, and sepsis. The clinical picture of bacterial vaginosis in pregnant women is the same as in non-pregnant women, namely homogeneous whitish-gray discharge from the genital tract, often with an unpleasant “fishy” smell, rarely itching and/or burning in the genital area and urethra, as well as soreness during urination (dysuria), with no signs of an inflammation detected in the genitals. Diagnosis of bacterial vaginosis in pregnant women, as well as in non-pregnant women, is based on the use of clinical and laboratory methods. Multiplex tests based on the nucleic acid amplification method, such as real-time polymerase chain reaction, are very popular for the diagnosis of bacterial vaginosis in this country. The Femoflor-16 Reagent Kit (DNA Technology CJSC, Moscow, Russia) is designed to detect the DNA of opportunistic microorganisms, lactobacilli DNA and human genomic DNA (as a control for taking biological material). Examination of pregnant women, especially in case of complaints of vaginal discharge, should be carried out when registering for pregnancy in order to start treatment early and prevent adverse pregnancy outcomes for the mother and fetus. Biofilms formed by microorganisms in bacterial vaginosis, especially G. vaginalis, limit the penetration of antibacterial agents to bacteria, their concentration being lower than therapeutic one, which leads to ineffective treatment. There remain many unexplored issues related to changes in the epidemiology of bacterial vaginosis, an increase in the frequency of relapses against the background of increasing resistance of microorganisms associated with bacterial vaginosis to antibiotics, and the development of agents that affect bacterial films.
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
Kristina Oganyan
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
编辑信件的主要联系方式.
Email: 2743856@mail.ru
ORCID iD: 0000-0002-1206-6029
SPIN 代码: 6276-4279
MD, Cand. Sci. (Med.)
俄罗斯联邦, Saint PetersburgAnna Krysanova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: krusanova.anna@mail.ru
ORCID iD: 0000-0003-4798-1881
SPIN 代码: 2438-0230
MD, Cand. Sci. (Med.)
俄罗斯联邦, Saint PetersburgAlevtina Savicheva
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: savitcheva@mail.ru
ORCID iD: 0000-0003-3870-5930
SPIN 代码: 8007-2630
MD, Dr. Sci. (Med.), Professor, Honored Worker of Science of the Russian Federation
俄罗斯联邦, Saint PetersburgOlesya Bespalova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: shiggerra@mail.ru
ORCID iD: 0000-0002-6542-5953
SPIN 代码: 4732-8089
MD, Dr. Sci. (Med.)
俄罗斯联邦, Saint PetersburgIgor Kogan
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: ikogan@mail.ru
ORCID iD: 0000-0002-7351-6900
SPIN 代码: 6572-6450
MD, Dr. Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences
俄罗斯联邦, Saint Petersburg参考
- Dibo M, Ventimiglia MS, Valeff N, et al. An overview of the role of probiotics in pregnancy-associated pathologies with a special focus on preterm birth. J Reprod Immunol. 2022;150. doi: 10.1016/j.jri.2022.103493
- Rossiyskoe obshchestvo dermatovenerologov i kosmetologov. Bakterial’nyy vaginoz. Klinicheskie rekomendatsii. 2022. (In Russ.) [cited 2023 Jul 16]. Available from: https://cr.minzdrav.gov.ru/recomend/206_2
- Barrow RY, Ahmed F, Bolan GA, et al. Recommendations for providing quality sexually transmitted diseases clinical services, 2020. MMWR Recomm Rep. 2020;68(5):1–20. doi: 10.15585/mmwr.rr6805a1
- Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol. 1955;69(5):962–76. doi: 10.1016/0002-9378(55)90095-8
- Diop K, Dufour JC, Levasseur A, et al. Exhaustive repertoire of human vaginal microbiota. Hum Microbiome J. 2019;11. doi: 10.1016/j.humic.2018.11.002
- Bitew A, Abebaw Y, Bekele D, et al. Prevalence of bacterial vaginosis and associated risk factors among women complaining of genital tract infection. Int J Microbiol. 2017;2017. doi: 10.1155/2017/4919404
- Onderdonk AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin Microbiol Rev. 2016;29:223–238. doi: 10.1128/CMR.00075-15
- Hillier SL, Nougent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995;333(26):1737–1742. doi: 10.1056/NEJM199512283332604
- Ugwumadu A, Manyonda I, Reid F, et al. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet. 2003;361(9362):983–988. doi: 10.1016/S0140-6736(03)12823-1
- Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ. 1999;319(7204):220–223. doi: 10.1136/bmj.319.7204.220
- Muzny CA, Schwebke JR. Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin Infect Dis. 2015;61(4):601–606. doi: 10.1093/cid/civ353
- Dikke GB. Bacterial vaginosis: novel aspects of etiology, pathogenesis, and selection of therapeutic strategy. Russian Journal of Woman and Child Health. 2019;2(4):307–313. (In Russ.) doi: 10.32364/2618-8430-2019-2-4-307-313
- Cox C, Watt AP, McKenna JP, et al. Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2016;35(3):481–487. doi: 10.1007/s10096-015-2564-x
- Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106(5):1013–1023. doi: 10.1097/01.AOG.0000183594.45524.d2
- Hardy L, Jespers V, Abdellati S, et al. A fruitful alliance: the synergy between Atopobium vaginae and Gardnerella vaginalis in bacterial vaginosis-associated biofilm. Sex Transm Infect. 2016;92(7):487–491. doi: 10.1136/sextrans-2015-052475
- Moi H, Fredlund H, Törnqvist E, et al. Mobiluncus species in bacterial vaginosis: aspects of pathogenesis. APMIS. 1991;99(11):1049–1054. doi: 10.1111/j.1699-0463.1991.tb01298.x
- Dabee S, Passmore JS, Heffron R, et al. The complex link between the female genital microbiota, genital infections, and inflammation. Infect Immun. 2021;89(5). doi: 10.1128/IAI.00487-20
- Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis. 2014;209(12):1989–1999. doi: 10.1093/infdis/jiu004
- Mendling W, Shazly MAE, Zhang L. The role of lactic acid in the management of bacterial vaginosis: a systematic literature review. Future Pharmacol. 2022;2(3):198–213. doi: 10.3390/futurepharmacol2030014
- Coudray MS, Madhivanan P. Bacterial vaginosis – a brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;245:143–148. doi: 10.1016/j.ejogrb.2019.12.035
- Savicheva AM, Shipitsyna EV. Bakterial’nyy vaginoz i be remennost’ (obzor literatury). Gynecology. 2012;14(3):38–43. (In Russ.)
- Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14–22. doi: 10.1016/0002-9343(83)91112-9
- Forsum U, Jakobsson T, Larsson PG, et al. An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis. APMIS. 2002;110(11):811–818. doi: 10.1034/j.1600-0463.2002.1101107.x
- Nazarova VV, Shipitsyna EV, Gerasimova EN, et al. Criteria for diagnosis of bacterial vaginosis using the test Femoflor-16. Journal of Obstetrics and Women’s Diseases. 2017;66(4):57–67. (In Russ.) doi: 10.17816/JOWD66457-67
- Rumyantseva T, Shipitsyna E, Guschin A, et al. Evaluation and subsequent optimizations of the quantitative AmpliSens Florocenosis/Bacterial vaginosis-FRT multiplex real-time PCR assay for diagnosis of bacterial vaginosis. APMIS. 2016;124(12):1099–1108. doi: 10.1111/apm.12608
- Shalepo KV, Nazarova VV, Menukhova YN, et al. Assessment of current methods of laboratory diagnosis of bacterial vaginosis. Journal of Obstetrics and Women’s Diseases. 2014;63(1):26–32. (In Russ.) doi: 10.17816/JOWD63126-32
- Savicheva AM. Modern ideas about the laboratory diagnosis of reproductively significant infections in women of reproductive age. Expert opinion. Issues of Practical Colposcopy Genital Infections. 2022;(3):34–39. (In Russ.) doi: 10.46393/27826392_2022_3_34
- Muzny CA, Kardas P. A narrative review of current challenges in the diagnosis and management of bacterial vaginosis. Sex Transm Dis. 2020;47(7):441–446. doi: 10.1097/OLQ.0000000000001178
- Brocklehurst P, Gordon A, Heatley E, et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013;(1). doi: 10.1002/14651858.CD000262.pub4
- Bacterial Vaginosis. Sexually Transmitted Infections Treatment Guidelines, 2021 [cited 2023 Aug 21]. Available from: https://www.cdc.gov/std/treatment-guidelines/bv.htm
- Siniakova AA, Shipitsyna EV, Budilovskaya OV, et al. The efficiency of treatment of vaginal infections in women with a history of miscarriage. Journal of Obstetrics and Women’s Diseases. 2019;68(5):63–74. (In Russ.) doi: 10.17816/JOWD68563-74
- Karapetyan TE, Lomova NA, Yusubova VR, et al. Bacterial vaginosis in pregnancy: a current view on diagnosis and therapy (literature review). Gynecology. 2019;21(5):30–34. (In Russ.) doi: 10.26442/20795696.2019.5.190667
- Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):375–390. doi: 10.1016/j.bpobgyn.2006.12.005
- Ijeoma CC, Nyengidiki TK, Bassey G, et al. Oral Clindamycin and Metronidazole in the treatment of bacterial vaginosis in pregnant black women: comparison of efficacy and pregnancy outcome. Clinical Journal of Obstetrics and Gynecology. 2020. doi: 10.29328/journal.cjog.1001040
- Thulkar J, Kriplani A, Agarwal N. A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis. Indian J Pharmacol. 2012;44(2):243–245. doi: 10.4103/0253-7613.93859
- Ajiji P, Uzunali A, Ripoche E, et al. Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol X. 2021;11. doi: 10.1016/j.eurox.2021.100128
- Sherrard J, Wilson J, Donders G, et al. European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258–1272. doi: 10.1177/0956462418785451.
- Bradshaw CS, Pirotta M, De Guingand D, et al. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS One. 2012;7(4). doi: 10.1371/journal.pone.0034540
- Lamont RF, Keelan JA, Larsson PG, et al. The treatment of bacterial vaginosis in pregnancy with clindamycin to reduce the risk of infection-related preterm birth: a response to the Danish Society of Obstetrics and Gynecology guideline group’s clinical recommendations. Acta Obstet Gynecol Scand. 2017;96(2):139–143. doi: 10.1111/aogs.13065
- Haahr T, Ersbøll AS, Karlsen MA, et al. Treatment of bacterial vaginosis in pregnancy in order to reduce the risk of spontaneous preterm delivery – a clinical recommendation. Acta Obstet Gynecol Scand. 2016;95(8):850–860. doi: 10.1111/aogs.12933
- Mendling W, Palmeira-de-Oliveira A, Biber S, et al. An update on the role of Atopobium vaginae in bacterial vaginosis: what to consider when choosing a treatment? A mini review. Arch Gynecol Obstet. 2019;300(1):1–6. doi: 10.1007/s00404-019-05142-8
- Bagnall P, Rizzolo D. Bacterial vaginosis: a practical review. JAAPA. 2017;30(12):15–21. doi: 10.1097/01.JAA.0000526770.60197.fa
- Paladine HL, Desai UA. Vaginitis: diagnosis and treatment. Am Fam Physician. 2018;97(5):321–329.
- Savicheva AM, Shalepo KV, Nazarova VV, et al. Sravnitel’noe kontroliruemoe randomizirovannoe issledovanie otsenki effektivnosti dvukhetapnogo lecheniya bakterial’nogo vaginoza. Gynecology. 2013;15(5):12–15. (In Russ.)
- Duckworth DH, Gulig PA. Bacteriophages: potential treatment for bacterial infections. BioDrugs. 2002;16(1):57–62. doi: 10.2165/00063030-200216010-00006
- Swidsinski A, Mendling W, Loening-Baucke V, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1). doi: 10.1016/j.ajog.2007.06.039.
- Wang Z, He Y, Zheng Y. Probiotics for the treatment of bacterial vaginosis: a meta-analysis. Int J Environ Res Public Health. 2019;16(20). doi: 10.3390/ijerph16203859
- Chen R, Li R, Qing W, et al. Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial. Reprod Health. 2022;19(1):137. doi: 10.1186/s12978-022-01449-z
- Chapman DK, Bartlett J, Powell J, et al. Bacterial vaginosis screening and treatment in pregnant women. J Midwifery Womens Health. 2016;61(5):628–631. doi: 10.1111/jmwh.12475
- Sousa LGV, Pereira SA, Cerca N. Fighting polymicrobial biofilms in bacterial vaginosis. Microb Biotechnol. 2023;16(7):1423–1437. doi: 10.1111/1751-7915.14261
补充文件
![](/img/style/loading.gif)